{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:16:16Z","timestamp":1791944176727,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.thromres.2020.08.024","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T22:28:32Z","timestamp":1597876112000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8588-8464","authenticated-orcid":false,"given":"Peijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-6519","authenticated-orcid":false,"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.08.024_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00005792-198601000-00004","article-title":"Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature","volume":"65","author":"Hughes","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2020.08.024_bb0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0954-6820.1966.tb05449.x","article-title":"Primary pulmonary hypertension with emphasis on its etiology and treatment","volume":"179","author":"Storstein","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.thromres.2020.08.024_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.thromres.2020.08.024_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003495-198631020-00006","article-title":"Drug treatment of primary pulmonary hypertension","volume":"31","author":"McLeod","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2020.08.024_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00129784-200404020-00002","article-title":"Drug therapy of primary pulmonary hypertension","volume":"4","author":"Nagaya","year":"2004","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.thromres.2020.08.024_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2020.08.024_bb0035","doi-asserted-by":"crossref","first-page":"237S","DOI":"10.1378\/chest.114.3_Supplement.237S","article-title":"Clinical insights into the pathogenesis of primary pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2020.08.024_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2020.08.024_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.112.3.714","article-title":"The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension","volume":"112","author":"Frank","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2020.08.024_bb0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.08.024_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3904\/kjim.2015.30.6.837","article-title":"Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension","volume":"30","author":"Kang","year":"2015","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.thromres.2020.08.024_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1253\/jcj.57.63","article-title":"Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension","volume":"57","author":"Ogata","year":"1993","journal-title":"Jpn. Circ. J."},{"key":"10.1016\/j.thromres.2020.08.024_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.08.024_bb0070","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.115.018435","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)","volume":"132","author":"Preston","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2020.08.024_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"key":"10.1016\/j.thromres.2020.08.024_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.thromres.2020.08.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12281","article-title":"Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil","volume":"35","author":"Ascha","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.thromres.2020.08.024_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/ol203060v","article-title":"Formal synthesis of antiplatelet drug, beraprost","volume":"14","author":"Reddy","year":"2012","journal-title":"Org. Lett."},{"key":"10.1016\/j.thromres.2020.08.024_bb0095","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2165\/11536000-000000000-00000","article-title":"Antiplatelet drugs\u2014do we need new options? With a reappraisal of direct thromboxane inhibitors","volume":"70","author":"Coccheri","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2020.08.024_bb0100","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/PCC.0b013e3181c76bab","article-title":"The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists","volume":"11","author":"Adatia","year":"2010","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.thromres.2020.08.024_bb0105","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1378\/chest.104.6.1690","article-title":"Platelet activation and fibrinopeptide formation in pulmonary hypertension","volume":"104","author":"Schulman","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2020.08.024_bb0110","first-page":"272","article-title":"Pulmonary emboli as cause of pulmonary hypertension","volume":"30","author":"Spotnitz","year":"1973","journal-title":"Ariz Med"},{"key":"10.1016\/j.thromres.2020.08.024_bb0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0272-5231(05)70283-5","article-title":"Pathobiology of pulmonary hypertension. The role of platelets and thrombosis","volume":"22","author":"Herve","year":"2001","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.thromres.2020.08.024_bb0120","first-page":"595","article-title":"Effect of warfarin anticoagulation on thrombin generation in patients with idiopathic pulmonary arterial hypertension","volume":"111","author":"Jansa","year":"2010","journal-title":"Bratisl LekListy"},{"key":"10.1016\/j.thromres.2020.08.024_bb0125","first-page":"1568830454","article-title":"The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study","author":"Jujo-Sanada","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.thromres.2020.08.024_bb0130","first-page":"24","article-title":"Cardiovascular disease update: pulmonary hypertension","volume":"454","author":"McDivitt","year":"2017","journal-title":"FP essentials"},{"key":"10.1016\/j.thromres.2020.08.024_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-2005-916156","article-title":"Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy","volume":"26","author":"Chakinala","year":"2005","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.thromres.2020.08.024_bb0140","first-page":"879","article-title":"Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis","volume":"30","author":"Caldeira","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.thromres.2020.08.024_bb0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ejhf.199","article-title":"Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study","volume":"17","author":"Goudie","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.thromres.2020.08.024_bb0150","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/S0041-1345(01)02539-8","article-title":"Prognosis in patients with primary pulmonary hypertension awaiting lung transplantation","volume":"33","author":"Ewert","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.thromres.2020.08.024_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1043-0679(98)70007-3","article-title":"Lung transplantation for pulmonary hypertension: patient selection and maintenance therapy while awaiting transplantation","volume":"10","author":"Rich","year":"1998","journal-title":"Semin Thorac CardiovascSurg"},{"key":"10.1016\/j.thromres.2020.08.024_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004757","article-title":"Is anticoagulation beneficial in pulmonary arterial hypertension?","volume":"11","author":"Khan","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482030462X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482030462X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:44:50Z","timestamp":1758735890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482030462X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":32,"alternative-id":["S004938482030462X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.024","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}